The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients (Q44834790)
Jump to navigation
Jump to search
scientific article published on 4 December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients |
scientific article published on 4 December 2003 |
Statements
1 reference
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients (English)
1 reference
Bob Löwenberg
1 reference
Pieter Sonneveld
1 reference
Petra Muus
1 reference
Gert J Ossenkoppele
1 reference
Wilfried J Graveland
1 reference
Simon M G J Daenen
1 reference
Douwe H Biesma
1 reference
Leo F Verdonck
1 reference
M Ron Schaafsma
1 reference
Petra H M Westveer
1 reference
Godefridus J Peters
1 reference
Paul Noordhuis
1 reference
Dominik Selleslag
1 reference
Bronnie van der Holt
1 reference
Michel Delforge
1 reference
Gregor E G Verhoef
1 reference
Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
1 reference
4 December 2003
1 reference
1 reference
103
1 reference
8
1 reference
2908-2913
1 reference
Identifiers
1 reference
1 reference